Home/Filings/4/0001209191-17-050642
4//SEC Filing

Chilcott, III Thomas E. 4

Accession 0001209191-17-050642

CIK 0001411906other

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 6:51 PM ET

Size

5.8 KB

Accession

0001209191-17-050642

Insider Transaction Report

Form 4
Period: 2017-08-23
Chilcott, III Thomas E.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-08-23+200,000200,000 total
    Exercise: $0.48Exp: 2027-08-23Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]This option shall vest as follows: (i) 100,000 shares of common stock vests on August 23, 2017 and (ii) 100,000 shares of common stock vests 365 days thereafter. In the event of a change in control of the Company or in the event of death, disability, termination without cause or for good reason (as such terms are defined in the Employment Agreement), all outstanding stock options held by the Reporting Person will become fully vested and exercisable.

Issuer

Ampio Pharmaceuticals, Inc.

CIK 0001411906

Entity typeother

Related Parties

1
  • filerCIK 0001709573

Filing Metadata

Form type
4
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 6:51 PM ET
Size
5.8 KB